Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.
作者信息
Lin J C, Zhang Z X, Smith M C, Biron K, Pagano J S
机构信息
Lineberger Cancer Research Center, School of Medicine, University of North Carolina, Chapel Hill 27514.
出版信息
Antimicrob Agents Chemother. 1988 Feb;32(2):265-7. doi: 10.1128/AAC.32.2.265.
Abstract
We show that the anti-human immunodeficiency virus agent, 3'-azido-3'-deoxythymidine (AZT), which suppresses infectivity and cytopathic effects of human immunodeficiency virus, also effectively inhibits Epstein-Barr virus (EBV) DNA replication. However, AZT has no effect on four other human herpesviruses: cytomegalovirus, varicella-zoster virus, and herpes simplex virus types 1 and 2. The combination of acyclovir and AZT, while it is not synergistic, has an additive effect against EBV replication. AZT may prove to be a useful drug for treatment of coinfections with human immunodeficiency virus and EBV.
摘要
相似文献
1
Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.
Antimicrob Agents Chemother. 1988 Feb;32(2):265-7. doi: 10.1128/AAC.32.2.265.
2
Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
IARC Sci Publ (1971). 1978(24 Pt 2):991-7.
3
Differential effect of arabinofuranosylthymine of the replication of human herpesviruses.
J Virol. 1977 Sep;23(3):679-84. doi: 10.1128/JVI.23.3.679-684.1977.
4
5
Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Antimicrob Agents Chemother. 1986 Dec;30(6):933-7. doi: 10.1128/AAC.30.6.933.
6
Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
Am J Med. 1982 Jul 20;73(1A):18-26. doi: 10.1016/0002-9343(82)90057-2.
7
The spectrum of antiviral activities of acyclovir in vitro and in vivo.
J Antimicrob Chemother. 1983 Sep;12 Suppl B:19-27. doi: 10.1093/jac/12.suppl_b.19.
8
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Proc Natl Acad Sci U S A. 1983 May;80(9):2767-70. doi: 10.1073/pnas.80.9.2767.
9
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
Antimicrob Agents Chemother. 1989 May;33(5):663-9. doi: 10.1128/AAC.33.5.663.
10
Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon.
Infect Immun. 1981 Jun;32(3):995-9. doi: 10.1128/iai.32.3.995-999.1981.
引用本文的文献
1
Human immunodeficiency virus and multiple sclerosis: a review of the literature.
Neurol Res Pract. 2019 Aug 20;1:24. doi: 10.1186/s42466-019-0030-4. eCollection 2019.
2
Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India.
Medicine (Baltimore). 2020 Jun 12;99(24):e20516. doi: 10.1097/MD.0000000000020516.
3
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.00980-19. Print 2019 Dec 15.
4
Could antiretrovirals be treating EBV in MS? A case report.
Mult Scler Relat Disord. 2018 May;22:19-21. doi: 10.1016/j.msard.2018.02.029. Epub 2018 Feb 27.
5
Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.
J Virol. 2000 Jan;74(2):684-92. doi: 10.1128/jvi.74.2.684-692.2000.
6
Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):34-41. doi: 10.1136/jnnp.65.1.34.
7
Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Drugs. 1993 Sep;46(3):515-578. doi: 10.2165/00003495-199346030-00010.
8
Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Drugs. 1989 Apr;37(4):408-50. doi: 10.2165/00003495-198937040-00003.
9
Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.
Clin Exp Immunol. 1991 Aug;85(2):209-13. doi: 10.1111/j.1365-2249.1991.tb05706.x.
10
Antiviral therapy: current concepts and practices.
Clin Microbiol Rev. 1992 Apr;5(2):146-82. doi: 10.1128/CMR.5.2.146.
本文引用的文献
1
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
J Virol. 1984 Apr;50(1):50-5. doi: 10.1128/JVI.50.1.50-55.1984.
2
Acyclovir and Epstein-Barr virus infection.
J Antimicrob Chemother. 1983 Sep;12 Suppl B:113-21. doi: 10.1093/jac/12.suppl_b.113.
3
Epstein-Barr virus: inhibition of replication by three new drugs.
Science. 1983 Aug 5;221(4610):578-9. doi: 10.1126/science.6306771.
4
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells.
Am J Med. 1982 Jul 20;73(1A):82-5. doi: 10.1016/0002-9343(82)90069-9.
5
In vitro susceptibility of varicella-zoster virus to acyclovir.
Antimicrob Agents Chemother. 1980 Sep;18(3):443-7. doi: 10.1128/AAC.18.3.443.
6
Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
J Infect Dis. 1980 May;141(5):563-74. doi: 10.1093/infdis/141.5.563.
7
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature. 1984;310(5974):207-11. doi: 10.1038/310207a0.
8
In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.
J Infect Dis. 1986 Dec;154(6):1027-30. doi: 10.1093/infdis/154.6.1027.
9
Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus.
J Virol. 1986 Nov;60(2):569-73. doi: 10.1128/JVI.60.2.569-573.1986.
10
Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis.
J Gen Virol. 1986 Oct;67 ( Pt 10):2267-72. doi: 10.1099/0022-1317-67-10-2267.
Zotero 插件